CMS just bolted the front door to Medicare for new home health and hospice providers. Everyone is reading it as a fraud story, and they are right. What most owners have not done yet is run the second-order math: the certification you have treated as paperwork is now the scarcest asset in the deal.
Here is how we see it playing out, the part of the analysis that runs against the obvious narrative, and what it means for the value of your business.
Goal
Most coverage of the May 13 moratorium stops at the enforcement angle. We want to go past it.
The question owners and investors are actually asking is blunt: does freezing new providers make my certified agency worth more, and does it speed up the deal market or stall it?
Our answer is yes to the first and it depends to the second. The reasoning is where the money is, so that is what this piece is about.
Key Takeaways
- On May 13, 2026, CMS froze new Medicare enrollment for home health agencies and hospices nationwide for six months, effective immediately.
- This is enforcement, not policy. Compliance is now a price lever, not a footnote.
- With new providers blocked, the only way into a market is to buy one that is already certified.
- Clean, transferable, seasoned certified agencies are worth more after the freeze than before it.
- The freeze unexpectedly hurts serial consolidators because many acquired agencies remain trapped inside the 36-month rule window.
- Deal structure shifts from asset to equity to preserve billing privileges.
- The most important number in your file is now the date of your last ownership change.
What This Article Covers
- What CMS did, in plain terms
- The part most owners are missing: this is a repricing event
- The 36-month rule is the whole story
- The contrarian read: the freeze hits consolidators hardest
- So is your agency worth more?
- Where we think the M&A market goes from here
- What this means for owners
- How Montauk AI helps
- The bottom line
- FAQ
What CMS Did, in Plain Terms
On May 13, CMS stopped accepting new Medicare enrollments from home health agencies and hospices nationwide for six months.
New agencies, new HHA branches, and new hospice locations are all on hold.
The agency moved under authority the Affordable Care Act gave it to pause enrollment of a provider type when it decides fraud prevention requires it.
The notices hit the Federal Register two days later.
What survives the freeze is the part that matters.
If you are already enrolled, you keep billing and keep operating.
If your application landed before May 13, you are fine.
And if a buyer acquires your business by stepping into your existing provider agreement, that deal can still close.
CMS did not freeze ownership changes. It froze the creation of new providers.
Those are different things, and the difference is the entire story.
The Part Most Owners Are Missing: This Is a Repricing Event
Read past the press release and you find a supply shock.
Every operator who wants into a market, or wants to expand inside one, has had two doors: build a new provider or buy an existing one.
The build door is bolted for at least six months, and likely longer.
That leaves one door.
When buying is the only way to grow, the growth capital that would have funded de novo development gets aimed at the same finite set of agencies that were certified on May 12.
Demand did not shrink. Supply did.
Strategic and sponsor-backed buyers suddenly found themselves in a market where acquisition is no longer one growth strategy among several. It is the only growth strategy left.
Their models assumed a blend of building and buying. The building line just went to zero, and the buying line has to carry the whole plan against a target pool that did not grow an inch.
The 36-Month Rule Is the Whole Story
If you absorb one mechanical detail, make it this one.
Medicare’s change of majority ownership rule — the 36-month rule — says that a home health agency or hospice that goes through a non-exempt majority ownership change within 36 months of its initial enrollment, or within 36 months of its last ownership change, has to re-enroll as a brand-new provider.
The old provider agreement terminates in that scenario.
Now lay the freeze on top.
Re-enrolling as a new provider is precisely what CMS will not do while the moratorium is in effect.
So any deal that trips the 36-month rule cannot close until the moratorium lifts.
A provider that enrolled recently, or changed hands recently, is stuck.
A provider safely past the window is free to move, and in this market that freedom carries a premium by itself.
The first thing we have a client do is pull the CMS-855A and find the date of the last change of ownership.
That one date tells you whether you own a sellable asset or a frozen one.
The Contrarian Read: The Freeze Hits Consolidators Hardest
Here is the part that runs against the obvious narrative.
The moratorium looks like a gift to the big platforms. Supply is constrained, they hold capital, they consolidate for a living.
But the serial acquirers built their portfolios by buying agencies, often inside the last three years.
That means a meaningful share of their own holdings is sitting inside the 36-month window today.
Those assets cannot be cleanly resold or restructured at the parent level without tripping re-enrollment.
The roll-up machine that made them efficient is the same machine that just trapped part of their inventory.
The quiet winner is less glamorous.
It is the compliant, single-site agency that enrolled five or six years ago, has not changed hands since, and was never flashy enough to draw a premium.
That agency is now clean, fully seasoned, and transferable in a market where those are suddenly rare.
In hospice especially, where consolidation was already crowded, this reshuffles who holds leverage.
The moratorium just gave well-positioned sellers more room to be selective.
So Is Your Agency Worth More? Yes, With Fine Print
Our answer is yes, and the fine print is the whole answer.
The premium does not spread evenly.
It collects in providers that are three things at once:
- Clean
- Simple
- Seasoned
Clean
A compliance and enrollment record that holds up while CMS, OIG, and DOJ are actively hunting.
The same announcement that created the scarcity also opened an enforcement season.
Simple
An ownership structure that does not raise 36-month questions and a provider agreement that can transfer cleanly in an equity deal.
Seasoned
Past the window and free to move.
Hit all three and you are selling the one thing a buyer cannot manufacture right now: continuity of billing privileges.
Miss them and the same financials get discounted for risk, wrapped in indemnities, or skipped.
This is where quality of earnings readiness has to grow a second half: quality of compliance readiness.
In this cycle, the regulator’s view of your file moves price as much as your EBITDA does.
The certification you treated as overhead just became the scarcest asset in the deal.
Most owners have not repriced it in their own heads yet.
Where We Think the M&A Market Goes From Here
Short term, the volume signal is mixed, and pretending otherwise would be dishonest.
Asset deals and anything that needs new enrollment will stall.
De novo and new-platform formation are paused outright.
Those transactions come off the board.
What is left moves faster and at firmer prices.
Equity deals that preserve the provider agreement become the default structure.
That routes more transactions through stock and membership-interest purchases.
That is not free.
A buyer taking the entity by equity inherits its past, including the successor liability an asset deal is built to avoid.
In an enforcement cycle that liability is not theoretical.
Expect deeper diligence, heavier reps and warranties, and bigger holdbacks.
Together, they widen the gap between headline price and cash at close.
Three Calls on Where This Heads
1. Plan for Extension
CMS has extended moratoria before, and the hospice side carries years of documented abuse behind it.
We would be surprised if six months is the end of it.
2. Compliance-First Diligence Is Here to Stay
The shift toward equity deals and compliance-first diligence outlasts the freeze.
Once buyers reprice enrollment risk, they do not un-learn it.
3. Watch the States
CMS invited state Medicaid programs to follow with their own moratoria.
If they do, agencies with heavy dual-eligible census face a second freeze stacked on the first.
Net of all of it: this accelerates M&A for clean, transferable, seasoned providers and freezes it for everyone else.
Acquisition is now the only growth lever for buyers who can no longer build, and disciplined capital is about to chase a fixed pool of quality targets.
If you own one of those targets, you have a window, and windows close.
What This Means for Owners
The work sorts into a clear order.
Find your last change-of-ownership date and your initial enrollment date.
Know your 36-month exposure before anyone else asks for it.
That number decides whether you can transact at all.
Stress-test your enrollment and compliance posture the way a buyer’s counsel will.
Counsel is going to read it during an active enforcement cycle.
Treat compliance as a value driver, not a paperwork chore.
Decide your structure tolerance early.
If the realistic path to close is an equity deal, understand the successor liability you would be handing a buyer, and price it before they do.
If you are getting inbound interest, take it seriously without taking it on the buyer’s terms.
A direct approach during the freeze usually means a buyer who has run out of de novo options.
That is leverage in your pocket.
Know the difference between an indication of interest and a letter of intent before you respond.
If a sale is twelve to twenty-four months out, none of this changes the plan — it compresses the runway.
The moratorium is the reason to start the work now rather than next quarter.
How Montauk AI Helps
The moratorium rewards a specific kind of business:
- Clean
- Seasoned
- Transferable
- Able to prove all three under scrutiny
That maps almost exactly to how we work.
Our Operate, Optimize, Exit framework was built to produce those qualities and, just as important, document them.
That documentation is the difference between an agency that captures the scarcity premium and one that watches it go to a competitor down the road.
Operate
We build the financial and reporting backbone that lets a clean agency prove it is clean.
A tight monthly close, KPI infrastructure, and board-ready reporting turn a defensible compliance and enrollment record into something a buyer’s counsel can verify quickly.
In an active enforcement cycle, provable beats plausible every time.
Optimize
We work on the fundamentals the moratorium did not touch.
Margin, census stability, payer mix, clinical quality, and workforce utilization still set your base value.
The scarcity premium is a multiplier on a real business, not a substitute for one.
We also map your 36-month exposure and your structure options early.
Exit
The moratorium makes process discipline matter more, not less.
When the only workable structure is often an equity deal, the buyer who wins is the one who values continuity of billing privileges and can underwrite your enrollment history with confidence.
We get ahead of the enrollment-history and successor-liability questions, structure around the 36-month rule, and run a controlled process that turns scarcity into your leverage instead of an opportunistic acquirer’s.
This is why a lifecycle advisor fits this moment better than a transactional broker.
A broker can list you.
It cannot make you transactable under the 36-month rule, defensible in an enforcement cycle, or worth the premium the market now pays for clean certified providers.
The Bottom Line
The moratorium did not create value out of thin air.
It exposed which providers were already valuable and made that value impossible to ignore.
The owners who win in this market are the ones who built a clean, seasoned, transferable business before any of this was news, and who can prove it on demand.
That is the difference between owning the door everyone now wants and owning a door nobody can open.
About Montauk AI
Montauk AI is a home-based care investment bank.
We work with founder-led and mid-market operators across home health, hospice, home care, palliative, and post-acute care across the full Operate, Optimize, Exit lifecycle.
In Operate, we build the FP&A foundation, KPI infrastructure, monthly close cadence, and board-ready reporting that defines a serious business.
In Optimize, we engineer enterprise value through EBITDA uplift, workforce utilization, clinical quality improvements, payer optimization, and technology enablement.
In Exit, we run the transaction through algorithmic buyer matching, CIM and comps strategy, and AI-accelerated execution.
We are tracking the moratorium and its enforcement aftermath on behalf of the operators we work with, and advising on the structuring and timing questions it forces.
For our extended treatment of the architecture behind this work, see our AI-Native Investment Banking research paper.
Considering an Exit in the Next Twelve to Twenty-Four Months?
The moratorium changed what your certification is worth and how a buyer can take it.
If you operate in home health, hospice, home care, palliative, or post-acute care and want a straight read on where your business sits relative to the 36-month rule, the enforcement cycle, and current buyer appetite for clean certified assets, we would welcome the conversation.
Reach Jarrett Bauer at jbauer@montauk.ai, or learn how we engage across Operate, Optimize, Exit at montaukai.com.
FAQ
What did CMS announce on May 13, 2026?
A six-month nationwide freeze on new Medicare enrollment for home health agencies and hospices, effective immediately, with notices published in the Federal Register on May 15.
During the freeze CMS will not approve new agencies, new HHA branches, or new hospice practice locations anywhere in the country.
The agency framed it as fraud prevention and can extend it in six-month increments.
Does the freeze stop all home health and hospice deals?
No.
It stops transactions that need a new Medicare enrollment, which includes asset deals and ownership changes that trip the 36-month rule.
It does not stop equity transactions where the buyer assumes the existing provider agreement and billing privileges.
The effect is a shift in how deals are structured, not a full stop.
Why would freezing new providers make existing agencies worth more?
Because it removes the build option.
When an operator cannot create a new certified provider, the only way to enter or expand a market is to buy one that already exists.
Capital that would have funded de novo development gets redirected at a fixed pool of certified agencies.
A clean, transferable provider agreement becomes the scarce input, and scarce inputs command a premium.
What is the 36-month rule, and why does it decide whether I can sell?
Medicare’s change of majority ownership rule requires a home health agency or hospice that undergoes a non-exempt majority ownership change within 36 months of its initial enrollment, or its last ownership change, to re-enroll as a new provider.
That new enrollment is exactly what the moratorium blocks.
A provider recently enrolled or recently sold may therefore be unable to transact until the freeze lifts.
The clock is now a gate, not a footnote.
Does this help the big consolidators?
Less than it looks.
Constrained supply favors well-capitalized buyers, but many serial acquirers bought agencies within the last three years.
That leaves a meaningful share of their own portfolio trapped inside the 36-month window.
The cleaner winner is often the compliant, single-site agency that enrolled years ago, has not changed hands, and is fully seasoned and transferable today.
What is the first thing I should check about my own agency?
The date of your last change of ownership and your initial Medicare enrollment date.
That tells you your 36-month exposure, which determines whether you can transact during the freeze at all.
It is the single most decision-relevant fact in your file while the moratorium is in effect.
How does deal structure change during the moratorium?
Buyers move toward equity or membership-interest purchases that preserve the provider agreement because asset deals requiring new enrollment cannot close.
Equity structures let a deal proceed but transfer the entity’s history to the buyer, including successor liability that asset deals usually avoid.
Expect deeper enrollment-history diligence, heavier reps and warranties, and larger holdbacks and escrows to allocate that risk.
Will the moratorium be extended?
CMS set it for six months and can extend it in six-month increments.
Our view is to plan for extension rather than assume a clean expiration.
CMS has extended prior moratoria before, and the enforcement posture behind this one is unlikely to disappear on a fixed date.
Will it accelerate or slow M&A overall?
Both, on different assets.
It accelerates M&A for clean, transferable, seasoned certified providers while freezing de novo growth and 36-month-encumbered assets.
For buyers who can no longer build, acquisition becomes the only growth lever, which concentrates disciplined capital onto a fixed pool of quality targets.
Headline deal count may look mixed in the short term, but activity and pricing for sellable certified assets should firm up.